A

Aprea Therapeutics
D

APRE

0.93850
USD
-0.01
(-1.21%)
مغلق
حجم التداول
912
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
6,563,717
أصول ذات صلة المقالات

العنوان: Aprea Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.